Oncomed Pharma
(OMED)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -26,071 | -22,235 | -15,034 | -27,015 |
| Depreciation Amortization | 1,378 | 1,295 | 942 | 2,565 |
| Income taxes - deferred | -10,331 | N/A | N/A | N/A |
| Accounts receivable | 4,000 | -4,023 | 9,000 | -4,000 |
| Accounts payable and accrued liabilities | 4,907 | -2,562 | N/A | N/A |
| Other Working Capital | 177,585 | -13,229 | 1,949 | 28,097 |
| Other Operating Activity | -6,874 | 7,409 | -8,143 | 4,855 |
| Operating Cash Flow | $144,594 | $-33,345 | $-11,286 | $4,502 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -57,287 | 38,727 | 9,654 | -700 |
| PPE Investments | -557 | -714 | -2,247 | -841 |
| Investing Cash Flow | $-57,844 | $38,013 | $7,407 | $-1,541 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | N/A | -346 | -703 | -726 |
| Common Stock Issued | 105,918 | 156 | 22 | 22 |
| Financing Cash Flow | $105,918 | $-190 | $-681 | $-704 |
| Beginning Cash Position | 16,263 | 11,785 | 16,345 | 14,088 |
| End Cash Position | 208,931 | 16,263 | 11,785 | 16,345 |
| Net Cash Flow | $192,668 | $4,478 | $-4,560 | $2,257 |
| Free Cash Flow | ||||
| Operating Cash Flow | 144,594 | -33,345 | -11,286 | 4,502 |
| Capital Expenditure | -557 | -714 | -2,247 | -841 |
| Free Cash Flow | 144,037 | -34,059 | -13,533 | 3,661 |